Bdh2 - 3-hydroxybutyrate dehydrogenase 2 Gene
Also Known as Dhrs6
Species: Rattus norvegicus
Summary
Predicted to enable 3-hydroxybutyrate dehydrogenase activity; NAD binding activity; and oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor. Predicted to be involved in several processes, including fatty acid beta-oxidation; heme metabolic process; and siderophore biosynthetic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm. Orthologous to human BDH2 (3-hydroxybutyrate dehydrogenase 2). [provided by Alliance of Genome Resources, Apr 2022]
Bdh2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001106473.1 | NP_001099943.1 | dehydrogenase/reductase SDR family member 6 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
dehydrogenase/reductase SDR family member 6 3-hydroxybutyrate dehydrogenase type 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01453 | BDH2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19878 | Bdh2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26377 | Bdh2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service